Search Results - "PARIKH, HEMANG M."

Refine Results
  1. 1
  2. 2
  3. 3

    Relationship between insulin sensitivity and gene expression in human skeletal muscle by Parikh, Hemang M, Elgzyri, Targ, Alibegovic, Amra, Hiscock, Natalie, Ekström, Ola, Eriksson, Karl-Fredrik, Vaag, Allan, Groop, Leif C, Ström, Kristoffer, Hansson, Ola

    Published in BMC endocrine disorders (27-02-2021)
    “…Insulin resistance (IR) in skeletal muscle is a key feature of the pre-diabetic state, hypertension, dyslipidemia, cardiovascular diseases and also predicts…”
    Get full text
    Journal Article
  4. 4

    Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis by You, Lu, Ferrat, Lauric A., Oram, Richard A., Parikh, Hemang M., Steck, Andrea K., Krischer, Jeffrey, Redondo, Maria J.

    Published in Diabetologia (01-11-2024)
    “…Aims/hypothesis Although statistical models for predicting type 1 diabetes risk have been developed, approaches that reveal the heterogeneity of the at-risk…”
    Get full text
    Journal Article
  5. 5

    Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07) by Zhao, Lue Ping, Papadopoulos, George K, Skyler, Jay S, Parikh, Hemang M, Kwok, William W, Bondinas, George P, Moustakas, Antonis K, Wang, Ruihan, Pyo, Chul-Woo, Nelson, Wyatt C, Geraghty, Daniel E, Lernmark, Åke

    Published in Diabetes care (01-09-2024)
    “…To explore if oral insulin could delay onset of stage 3 type 1 diabetes (T1D) among patients with stage 1/2 who carry HLA DR4-DQ8 and/or have elevated levels…”
    Get full text
    Journal Article
  6. 6

    155-OR: Genetic Variation and Time to Progression in TN10 (Teplizumab) by MICHALEK, DOMINIKA A., ONENGUT-GUMUSCU, SUNA, CHEN, WEI-MIN, BRUSKO, TODD M., STECK, ANDREA, GOTTLIEB, PETER, ORAM, RICHARD A., KRISCHER, JEFFREY, PARIKH, HEMANG M., REDONDO, MARIA J., HEROLD, KEVAN C., RICH, STEPHEN S.

    Published in Diabetes (New York, N.Y.) (14-06-2024)
    “…Introduction & Objective: TN10 Anti-CD3 Prevention (TN10) was a randomized phase 2 clinical trial that showed teplizumab delayed progression to type 1 diabetes…”
    Get full text
    Journal Article
  7. 7

    Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives by Triolo, Taylor M, Parikh, Hemang M, Tosur, Mustafa, Ferrat, Lauric, You, Lu, Gottlieb, Peter A, Oram, Richard A, Onengut-Gumuscu, Suna, Krischer, Jeffrey P, Rich, Stephen S, Steck, Andrea K, Redondo, Maria J

    “…We sought to determine whether the type 1 diabetes genetic risk score-2 (T1D-GRS2) and single nucleotide polymorphisms (SNPs) are associated with C-peptide…”
    Get full text
    Journal Article
  8. 8

    1254-P: Genetic Prediction of C-Peptide Trajectory before Type 1 Diabetes Diagnosis in TrialNet by TRIOLO, TAYLOR M., PARIKH, HEMANG M., TOSUR, MUSTAFA, GOTTLIEB, PETER, ORAM, RICHARD A., ONENGUT-GUMUSCU, SUNA, KRISCHER, JEFFREY, RICH, STEPHEN S., STECK, ANDREA, REDONDO, MARIA J.

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Modeling the course of C-peptide decline in autoantibody (Ab) positive individuals is important for type 1 diabetes (T1D) prediction and implementation of T1D…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes by Parikh, Hemang M, Remedios, Cassandra L, Hampe, Christiane S, Balasubramanyam, Ashok, Fisher-Hoch, Susan P, Choi, Ye Ji, Patel, Sanjeet, McCormick, Joseph B, Redondo, Maria J, Krischer, Jeffrey P

    “…Abstract Context Some individuals present with forms of diabetes that are “atypical” (AD), which do not conform to typical features of either type 1 diabetes…”
    Get full text
    Journal Article
  11. 11
  12. 12

    216-LB: Genetic Influences on Beta-Cell Function before Type 1 Diabetes Diagnosis by TRIOLO, TAYLOR M., PARIKH, HEMANG M., TOSUR, MUSTAFA, FERRAT, LAURIC A., YOU, LU, GOTTLIEB, PETER, ORAM, RICHARD A., ONENGUT-GUMUSCU, SUNA, KRISCHER, JEFFREY, RICH, STEPHEN S., STECK, ANDREA, REDONDO, MARIA J.

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Autoimmune loss of beta-cell function (measured by C-peptide) is the hallmark of type 1 diabetes (T1D) targeted by interventions that aim to prevent T1D or its…”
    Get full text
    Journal Article
  13. 13
  14. 14

    243-OR: Integrating Genetic Risk Score and Islet Autoantibody Characteristics in the Predictive Model for Type 1 Diabetes in the TrialNet Study by FERRAT, LAURIC A., STECK, ANDREA, PARIKH, HEMANG M., YOU, LU, ONENGUT-GUMUSCU, SUNA, GOTTLIEB, PETER, RICH, STEPHEN S., KRISCHER, JEFFREY, ORAM, RICHARD A., REDONDO, MARIA J.

    Published in Diabetes (New York, N.Y.) (01-06-2021)
    “…Background: Type 1 diabetes (T1D) genetic risk score (GRS) and islet autoantibody (AAb) specificity and titers influence T1D risk; however, these factors…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    1462-P: Genetic Risk Score for Type 1 Diabetes across Ethnic Populations via Multitask Learning by Li, Mingqian, Lin, Feng, Zhang, Congjing, Vehik, Kendra, Parikh, Hemang M, Oram, Richard A, Qian, Xiaoning, Huang, Shuai

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction: Genetic risk scores (GRS) for the prognosis of Stage 3 type 1 diabetes (T1D) are potentially biased due to the predominant race/ethnicity…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20